British Columbia source: bounded use
This British Columbia guideline covers investigation and selected management decisions for suspected urinary tract infection in adults aged 16 years and older. Individual antibiotic regimens and paediatric UTI are outside its scope.
sources for this section:BC UTI
Source-attributed clinical priorities
- Distinguish symptomatic lower infection from pyelonephritis, sexually transmitted infection, vaginitis and asymptomatic bacteriuria.
- Use urine testing when it can change management and obtain culture for complicated, recurrent, resistant-risk or upper-tract infection.
- When treatment is indicated, use the current local antimicrobial resource and review culture results and clinical response.
- Asymptomatic bacteriuria generally should not be treated outside defined Canadian indications such as pregnancy or selected procedures.
sources for this section:BC UTI
Practical assessment and management workflow
1
Localize lower versus upper infection from fever, flank pain, systemic features and examination.
2
Use dipstick selectively and obtain a properly collected culture when recurrence, treatment failure, pregnancy or resistance risk makes it useful.
3
Decide whether empiric treatment is warranted from compatible symptoms, host risk and pregnancy, then consult the current local antimicrobial resource.
4
Review culture and clinical response and investigate recurrent or nonresolving infection appropriately.
sources for this section:BC UTI
Safety, red flags and urgent escalation
- Escalate sepsis, obstruction, pregnancy pyelonephritis, vomiting or inability to maintain hydration.
- Gross hematuria without infection symptoms requires a urology pathway rather than repeated UTI treatment.
- Avoid repeated testing or antibiotics for chronic urinary symptoms, cloudy urine or delirium alone without compatible infection features.
sources for this section:BC UTI
Confirm the local pathway before acting
British Columbia is used as an explicit Canadian implementation example, not as a national rule. Verify the equivalent pathway, formulary and escalation route in the patient’s province or territory.
sources for this section:BC UTI
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:BC UTI
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Government of British ColumbiaUrinary Tract Infections in the Primary Care Setting – InvestigationEffective 2020-07-29 · accessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.